ALX ONCOLOGY HOLDINGS INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ALX ONCOLOGY HOLDINGS INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 14.15K shares, a 96.84% decline from fiscal 2024.
- ALX ONCOLOGY HOLDINGS INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 447.05K shares, a 722.41% increase from fiscal 2023.
- ALX ONCOLOGY HOLDINGS INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 54.36K shares, a 68.37% decline from fiscal 2022.
- ALX ONCOLOGY HOLDINGS INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 171.84K shares, a 76.62% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 14.15K shares 10-K · filed 2026-03-09 | |
| 2024-12-31 | 447.05K shares 10-K · filed 2025-03-06 | |
| 2023-12-31 | 54.36K shares 10-K · filed 2024-03-07 | |
| 2022-12-31 | 171.84K shares 10-K · filed 2023-03-09 | |
| 2021-12-31 | 734.92K shares 10-K · filed 2022-02-28 | |
| 2020-12-31 | 182.11K shares 10-K · filed 2021-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |